ArticleDalton transactions (Cambridge, England : 2003)2023
Visible light-activatable platinum(IV) prodrugs harnessing CD36 for ovarian cancer therapy.
Amarasooriya M D S Jayawardhana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it